Quest Partners LLC Sells 6,425 Shares of Balchem Co. (NASDAQ:BCPC)

Quest Partners LLC lessened its stake in shares of Balchem Co. (NASDAQ:BCPC) by 77.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,843 shares of the basic materials company’s stock after selling 6,425 shares during the quarter. Quest Partners LLC’s holdings in Balchem were worth $324,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of BCPC. nVerses Capital LLC bought a new stake in shares of Balchem during the third quarter worth $35,000. Bessemer Group Inc. lifted its holdings in shares of Balchem by 568.9% during the first quarter. Bessemer Group Inc. now owns 301 shares of the basic materials company’s stock worth $47,000 after purchasing an additional 256 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Balchem by 73.4% during the third quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock worth $148,000 after purchasing an additional 356 shares during the period. Blue Trust Inc. lifted its holdings in shares of Balchem by 642.5% during the third quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock worth $148,000 after purchasing an additional 726 shares during the period. Finally, TD Asset Management Inc acquired a new position in shares of Balchem during the second quarter worth $200,000. Institutional investors own 87.91% of the company’s stock.

Analysts Set New Price Targets

BCPC has been the topic of a number of recent research reports. HC Wainwright lifted their price target on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th. StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

Balchem Price Performance

BCPC stock opened at $182.69 on Tuesday. The firm has a market cap of $5.94 billion, a price-to-earnings ratio of 49.11, a PEG ratio of 5.45 and a beta of 0.65. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. Balchem Co. has a 12-month low of $120.87 and a 12-month high of $186.03. The company’s fifty day simple moving average is $173.84 and its 200 day simple moving average is $166.71.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.